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Abstract
Background: Previous population-based studies showed differences in international and within country colorectal
cancer survival estimates, but few investigated the role of prognostic factors. Using a “high resolution approach”,
we aimed to determine the effect of ethnicity and health care by comparing Filipino-Americans with Philippine
residents, who have the same ethnicity, and with Caucasians living in the US, who have the same health care
system.
Methods: Using databases from the Manila and Rizal Cancer Registries and the United States Surveillance,
Epidemiology and End Results, age-adjusted five-year absolute and relative survival estimates were computed and
compared between Filipino-American colorectal cancer patients, cancer patients from the Philippines and
Caucasian patients. Cox proportional hazards modelling was used to determine factors affecting survival
differences.
Results: Much lower 5-year relative survival estimates were obtained for Philippine residents (37%) as compared to
those in Filipino-Americans (60.3%) and Caucasians (62.4%). Differences in age, stage and receipt of surgery
explained a large proportion of the survival differences between Philippine residents and Filipino-Americans.
However, strong excess risk of death for Philippine residents remained after controlling for these and other
variables (relative risk, RR, 2.03, 95% confidence interval, 95% CI, 1.83-2.25).
Conclusions: Strong survival disadvantages of Philippine residents compared to Filipino-American patients were
disclosed, which most likely reflect differences in access to and utilization of health care. Health education and
advocacy, for both patients and health practitioners, should likewise be given priority.
Background
Colorectal cancer (CRC) is among the most common
cancers worldwide, ranking fourth in men and third in
women [1]. Incidence is higher in developed countries
than in less developed nations, with the ratio of colon to
rectal cancer incidence being 2:1 in the high-risk coun-
tries as compared to an almost equal distribution in
low-risk nations [1]. Similarly, survival estimates were
also reported to be higher in developed countries, with
the exception of Eastern Europe, in comparison to less
developed nations [1,2].
Within countries, incidence, mortality and survival rates
were reported to vary. In the United States, incidence and
mortality among Caucasians were lower than among Afri-
can-Americans, but higher than among Asian and Pacific
Islanders (API) and Hispanics [3]. Five-year survival was
found similar in non-Hispanic whites (NHW) and Asian
Americans, including Filipino-Americans [4-6].
While international and interracial CRC survival com-
parisons have been reported, high resolution studies that
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stage and treatment, are rare [2,4,5,7]. The term “high
resolution study” was first used by the EUROCARE
group in comparing cancer survival estimates between
populations in Europe, and aims to elucidate possible
explanations for survival differences [7-9]. It incorpo-
rates information that are usually not available in stan-
dard format in population-based registries, such as
disease stage and treatment.
In previous studies, variations in access to diagnostic
and treatment facilities were put forward as the reasons
for survival differences between countries and popula-
tions [2,4,7]. However, it was also found that biological
characteristics, such as age at disease onset and tumor
differentiation, vary between ethnic groups [5]. Few stu-
dies tried to disentangle how much of cancer survival
discrepancies between ethnic groups are explained by
ethnicity or by health care conditions.
Furthermore, there is also a dearth of published popu-
lation-based colorectal cancer survival estimates from
developing countries, and comparisons of these with
data from developed countries are limited [2,10,11].
Such comparisons are important to determine discre-
pancies in access to and utilization of cancer care ser-
vices between developed and less developed nations.
From the Philippines, population-based cancer survival
data were reported for the first time in the 1998 Inter-
national Agency for Research on Cancer (IARC) mono-
graph “Cancer Survival in Developing Countries” [12],
a n do n l ym o r er e c e n t l yi nasummary report for this
study [13]. Compared to most populations from devel-
oped countries, a huge majority of Philippine residents
do not have heath insurance and bear the cost of health
care from out-of-pocket funds [14]. These circumstances
are likely to play a significant role in access to cancer
care services, and in turn, to health outcomes, and
should be studied further.
To elucidate the role of various factors, including eth-
nicity, stage at diagnosis, and access to treatment in
CRC survival, we compared Filipino-Americans with
Philippine residents, who have the same ethnicity, and
with Caucasians living in the US, who are exposed to
similar health care systems.
Methods
Databases
US SEER
Using the United States Surveillance, Epidemiology and
End Results (SEER) 13 database [15], CRC patients iden-
tified to be of Filipino or of Non-Hispanic White ethni-
city were selected. Patients aged 15 and older, diagnosed
from January 1, 1993 to December 31, 2002, and fol-
lowed with respect to vital status until December 31,
2002 were included in the study. In situ cases and those
who were identified by death certificates only (DCO) or
autopsy only, which consist <1% of cases, were excluded,
leaving 2,671 Filipino-American and 133,551 Caucasian
patients to be included in the analysis.
Philippine Resident Population
Information on CRC cases who were residents of the
National Capital Region (NCR) were abstracted from
the databases of the Philippine Cancer Society-Manila
Cancer Registry (PCS-MCR) and the Department of
Health-Rizal Cancer Registry (DOH-RCR). The PCS-
MCR covers the four major cities of the NCR (Manila,
Quezon City, Pasay and Caloocan), while the DOH-RCR
covers the 12 municipalities of the former Rizal province
that were incorporated into the NCR and the present
Rizal Province. The NCR holds the seat of the Philip-
pine government and is the largest urban metropolis,
and the political, social, educational and economic
center.
Data collection procedures include exhaustive identifi-
cation and collection of information on patients from all
hospitals in the NCR and the Rizal Province, which lim-
its underreporting to a minimum. Various patient
records were reviewed, including medical, pathology,
radiotherapy, radiology, ultrasound, nuclear medicine
and CT scan reports, and records from hospital tumor
registries, if available. Death certificate notifications
(DCN) indicating cancer as the cause of death are also
routinely acquired by the registries from all the Local
Civil Registry Offices in the constituent cities.
The Philippine registries are regarded as among the
high-quality cancer registries from developing countries
and have consistently been included in Cancer Incidence
in Five Continents [16-20]. They follow the cancer regis-
tration definitions and data collection guidelines set by
the International Agency for Research on Cancer
(IARC) and the International Association of Cancer
Registries (IACR).
The same inclusion and exclusion criteria as for the
SEER databases were used in the subject selection. For
t h eP h i l i p p i n ed a t at h o u g h ,d u et ol i m i t e dr e s o u r c e s ,
only subsamples of 200 cases diagnosed in each calendar
year from 1993 to 2002 were randomly selected from
the 7,769 eligible CRC patients in the database. These
were followed with respect to vital status until Decem-
ber 31, 2002 and included in the analysis. From DCNs
mentioning cancer as the cause of death, survival status
was assessed. Active follow-up by personal visits to the
patients or their families in the last known place of resi-
dence was used to confirm status for those not identi-
fied as dead.
From the 2000 randomly sampled patients, 160 (8%)
were excluded from the analysis due to invalid data
while an additional 205 (10.2%) were removed due to
the absence of any follow-up information. Anonymized
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patients (81.8%) were prepared and used in the analysis.
Of these, 83.6% have complete follow-up information.
Of the patients who are alive, 68.6% have complete fol-
low-up information. For survival analyses, patients with
incomplete follow-up information were censored at the
last date known alive.
From the patients who have complete follow-up infor-
mation, 53.9% were identified to be deceased, of whom
98.2% have cancer as the cause of death. For 82.3% of
patients who are dead, information on the cause of
death was obtained from medical records or death certi-
ficates, while data for another 12.6% were acquired
through interviews of family members. Survival informa-
tion for only a few (5.1%) came from other sources.
The project proposal was approved by the Ethics
Review Board of the National Institutes of Health of the
University of the Philippines Manila.
Data analysis
Estimation of Survival using Period Analysis
Conventionally, cohort-based analyses, using the life-
table (actuarial) method or the Kaplan-Meier method
[21,22], have been used to derive cancer survival esti-
mates. In this study, however, we employed period ana-
lysis, introduced by Brenner and Gefeller in 1996, to
derive more up-to-date survival estimates [23]. With
this approach, only the survival experience of patients
during the most recent calendar period for which data
are available are included. Various empirical studies
have shown that period analysis provides more up-to-
date estimates of survival that closely predict survival
later observed for patients diagnosed in the respective
period [24-28].
Estimation of Relative Survival
As commonly practiced in population-based survival
analysis, estimates of relative survival (calculated as the
ratio of observed and expected survival) are reported, in
addition to estimates of absolute survival. Expected sur-
vival for the general population of analogous age distri-
bution was derived using the so-called Ederer II method
[29] and life tables for the year 2000. Due to the absence
of life tables for other races, the life table for whites
from the US National Center for Health Statistics [30]
was used for both SEER populations. The life table for
the Philippine resident population was derived from the
projected population estimate and the actual mortality
data for this area, which were obtained from the Philip-
pine National Statistics Office. To compare overall CRC
survival estimates between the different cancer popula-
tions, age adjustment was done using weights from the
World Standard Cancer Patient Population (WSCPP)
[12]. Age groups used were less than 50, 50-59, 60-69,
70-79 and 80 and above.
Tests for survival differences between cancer populations
To test for differences in survival between the three
cancer populations, a novel modelling approach for
period analysis [31] was used. First, age-specific num-
bers of patients at risk and of deaths by year of follow-
up were calculated separately for each population
group. Then, Poisson regression models were fitted, in
which the numbers of deathsw e r em o d e l l e da saf u n c -
tion of the population group (Philippine residents or
Filipino-Americans or Caucasians), year of follow-up
(1, 2, 3, 4, 5 - entered as a categorical variable) and
age-group (15-49, 50-59, 60-69, 70-79 and 80+ -
entered as a categorical variable), using the logarithm
of the person-years at risk as offset, and accounting for
late entries and withdrawals as half persons, as
described in detail elsewhere [31]. This approach
allowed testing for significance of differences in survi-
val, after adjustment for age, based on p-values for the
population parameter estimate. A significance level of
alpha = 0.05 (two-sided testing) was used.
Multivariate analysis
To explain possible survival differences and to deter-
mine factors affecting survival, both within and between
the three cancer patient populations, the Cox Propor-
tional Hazards model was used. Initially, separate Cox
models by population group were used to determine
b i v a r i a t ea s s o c i a t i o n so fa g e ,s e x ,s t a g e ,h i s t o l o g y ,s u r -
gery and radiotherapy with survival. A multivariate
model was then built jointly for all three groups to com-
pare survival probabilities between populations. Relative
risks were calculated using Filipino-Americans as the
reference group, while controlling for the effects of age,
sex, stage, histology, surgery and radiotherapy, first indi-
vidually and then simultaneously. Those with missing
information were excluded in the multivariate analysis.
For each variable included in the Cox models, the pro-
portional hazards assumption was checked by using log
(-log) graphs. The plotted lines were roughly parallel
over time and no violations of the proportional hazards
assumption were found.
Age at diagnosis was categorized into the 5 age adjust-
ment groupings mentioned earlier. Stage categories were
localized, regional and distant, while histology was clas-
sified based on the WHO Classification of Tumours
[32] (adenocarcinoma and other types). Binary variables
(with/without) were used for the receipt of surgical
treatment and of radiotherapy. Chemotherapy and hor-
mone therapy were not included in the Cox models as
these were not available from the SEER public use data-
base. Nevertheless, a sub-analysis for the receipt of che-
motherapy was done for the Philippine residents.
To account for missing infor m a t i o ni nt h ed a t a b a s e s ,
multiple imputation [33] using a Markov Chain Monte
Carlo method was done. Parameter estimates were
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The PROC MI and MIANALYSIS commands in the
SAS Statistical Analysis Software were used to perform
these analyses. All analyses were done with the SAS Sta-
tistical Analysis Software version 9.2 [34]. Special
macros were used for standard and modelled period sur-
vival analysis as previously described [31,35].
Results
The distribution of cases for each population group by
specific cancer site, sex, age group, stage, histology, sur-
gery and radiotherapy are shown in Table 1. Colon and
rectum cancer were about equally common for the Phi-
lippine residents, whereas the proportion of colon can-
cers was much larger for both SEER populations. The
sex distribution was almost equal in all groups. Cauca-
sians on average were older than the other patient
groups, with more than half aged 70 or above, while
Filipinos residing in the Philippines were youngest with
almost 50 percent below 60 years of age. Both US SEER
populations were diagnosed at earlier stages than Filipi-
nos in the Philippines, with larger proportions of
patients presenting with localized tumors. In all three
population groups, adenocarcinomas are the predomi-
nant histological type, between 80 and 90% of patients
underwent surgery and less than 15% received radio-
therapy. The random sample of Philippine resident
patients was representative of all registered eligible CRC
cases with respect to socio-demographic characteristics
(data not shown).
Age adjusted overall, site- and sex-specific estimates,
as well as age specific estimates of absolute and relative
5-year cancer survival are shown in Table 2. Generally,
much lower survival was seen in Filipinos living in the
Table 1 Tumor and socio-demographic characteristics of colorectal cancer patients among the Philippine resident
population and Filipino-Americans and Non-Hispanic Whites from US SEER, 1993-2002
Variable Philippine resident population
(N = 1635)
Filipino-Americans
(N = 2671)
Non-Hispanic Whites
(N = 133551)
p-value
Freq % Freq % Freq %
Site
Colon 829 50.7 1663 62.3 97150 72.7 <0.0001
Rectum 806 49.3 1008 37.7 36401 27.3
Sex
Male 851 52.1 1514 56.7 66908 50.1 <0.0001
Female 784 48.0 1157 43.3 66643 49.9
Age group
<50 424 25.9 357 13.4 8648 6.5 <0.0001
50-59 359 22.0 483 18.1 15703 11.8
60-69 416 25.4 674 25.2 28436 21.3
70-79 331 20.2 692 25.9 43704 32.7
80+ 105 6.4 465 17.4 37060 27.8
Stage
Localized 332 29.9 1009 39.9 53532 42.2 <0.0001
Regional 507 45.6 1019 40.2 49179 38.8
Distant 272 24.5 504 19.9 24139 19.0
Unknown 524 139 6701
Morphology
Adenocarcinoma 1205 85.6 1820 69.7 87048 67.3 <0.0001
Others 202 14.4 791 30.3 42351 32.7
NOS
1 228 60 4152
Surgery
With surgery 1121 81.1 2350 88.0 118460 88.8 <0.0001
Without surgery 262 18.9 320 12.0 14936 11.2
Unknown 252 1 155
Radiotherapy
With radiotherapy 168 14.3 382 14.4 14188 10.7 <0.0001
Without radiotherapy 1008 85.7 2263 85.6 118309 89.3
Unknown 459 26 1054
1includes: Neoplasms; Carcinoma, NOS
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differences were observed between Filipino-Americans
and Caucasians. Within all three population groups,
prognosis was very similar for colon and rectal cancer
patients. Women have slightly higher survival than
males in the SEER populations, but the sex difference is
more pronounced among the Philippine residents.
As shown in Table 3, advanced stage at diagnosis and
not receiving surgery were strongly related to the risk of
dying in each of the three populations. A histologic type
other than adenocarcinoma was associated with better
prognosis in the US cancer populations. A sub-analysis
among the Philippine residents showed that not receiv-
ing chemotherapy was also related to the risk of death
(RR, 1.31; 95% CI 1.08-1.58).
In bivariate comparative survival analysis between popu-
lation groups (table 4), substantial excess risk of death was
seen among CRC patients from the Philippines as com-
pared to Filipino-American patients. Excess overall mor-
tality was further increased when controlling for age, and
was substantially reduced when controlling for receipt of
surgery. Nevertheless, quite substantial excess overall mor-
tality was found (RR, 2.03; 95% CI, 1.83-2.25) after control-
ling for these and other factors in multivariate analysis.
The small excess risk of Caucasian CRC patients com-
pared to Filipino-American CRC patients seen in bivariate
analysis was mostly explained by the age differences, but a
slight excess mortality for Caucasian patients remained
after controlling for age and other covariates in multivari-
ate analysis (RR, 1.12, 95% CI 1.04-1.20).
Discussion
This high-resolution study disclosed large survival defi-
cits between Philippine resident CRC patients compared
Table 2 Five-year absolute and relative survival (in %) of colorectal cancer patients adjusted to the World Standard
Cancer Patient Population, Philippine resident population, and Filipino-Americans and Non-Hispanic Whites from US
SEER, 1998-2002
Variable (1) Philippine resident
population
Between (1) and
(2)
(2) Filipino-
Americans
Between (2) and
(3)
(3) Non-Hispanic
Whites
% SE Diff p-value % SE Diff p-value % SE
Absolute survival
Over all survival
1 26.7 2.2 22.3 <0.001 49.0 1.3 1.3 0.74 50.3 0.2
Site
1
Colon 27.8 2.8 20.8 <0.001 48.6 1.7 1.6 0.73 50.2 0.2
Rectum 26.0 3.6 23.7 <0.001 49.7 2.2 0.2 0.84 49.9 0.4
Sex
1
Male 22.2 2.6 25.3 <0.001 47.5 1.7 0.4 0.86 47.9 0.3
Female 31.7 3.5 20.1 <0.001 51.8 2.2 0.9 0.92 52.6 0.3
Age group
<50 34.7 4.1 29.0 <0.001 63.7 3.8 2.5 0.72 66.2 0.7
50-59 37.7 4.5 29.3 <0.001 67.0 3.1 -1.7 0.44 65.3 0.5
60-69 27.8 4.0 32.8 <0.001 60.7 2.7 -1.5 0.75 59.2 0.4
70-79 34.0 5.0 17.0 <0.001 50.9 2.7 -0.9 0.43 50.0 0.3
80+ 10.6 4.9 13.2 0.06 23.8 2.7 6.0 0.03 29.8 0.3
Relative survival
Over all survival
1 37.0 4.2 23.2 <0.001 60.3 1.9 2.2 0.85 62.4 0.3
Site
1
Colon 37.3 4.9 22.3 <0.001 59.6 2.4 3.0 0.82 62.6 0.3
Rectum 37.9 7.4 23.5 <0.001 61.4 3.3 -0.4 0.87 61.0 0.5
Sex
1
Male 30.2 5.0 29.2 <0.001 59.5 2.5 1.5 0.76 61.0 0.4
Female 42.9 6.2 18.7 <0.001 61.6 3.0 2.1 0.98 63.7 0.3
Age group
<50 35.7 4.3 29.0 <0.001 64.6 3.8 2.6 0.73 67.2 0.7
50-59 40.6 4.9 29.0 <0.001 69.6 3.2 -1.6 0.44 68.0 0.6
60-69 32.8 4.8 34.1 <0.001 66.9 3.0 -1.4 0.91 65.5 0.5
70-79 51.5 7.6 12.4 <0.01 63.9 3.4 -0.7 0.32 63.2 0.4
80+ 26.6 12.3 19.6 0.42 46.1 5.2 8.9 0.07 55.0 0.6
Diff, difference; SE, standard error
1also adjusted by age
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favourable prognosis in comparison to Caucasians in the
US. Further analysis showed that Filipinos were less
likely to be diagnosed at a localized stage, indicating
delay in disease detection.
In spite of the availability of early detection methods
for CRC, most patients in the Philippines are still
diagnosed with an advanced stage disease. From the
onset of symptoms, average delay of physician consulta-
tion was estimated to be 5 months, while average delay
in diagnosis was estimated to be 7 months [36]. On the
part of the patients, financial constraints were the main
reasons cited for this delay [36], with patients consulting
health practitioners only when symptoms become
Table 3 Relative risk of death according to various prognostic factors among colorectal cancer patients, Philippine
resident population and from Filipino-Americans and Non-Hispanic Whites from US SEER, 1993-2002, Bivariate
analysis
Variable Philippine resident population Filipino-Americans Non-Hispanic Whites
RR 95% CI RR 95% CI RR 95% CI
Sex
Male 1.00 1.00 1.00
Female 0.94 0.82 - 1.09 0.85 0.76 - 0.97 1.00 0.98 - 1.01
Age group
<50 1.00 1.00 1.00
50-59 0.98 0.79 - 1.22 0.85 0.66 - 1.11 1.04 0.99 - 1.09
60-69 1.03 0.84 - 1.27 1.18 0.94 - 1.49 1.28 1.23 - 1.34
70-79 1.07 0.86 - 1.34 1.53 1.23 - 1.91 1.75 1.68 - 1.83
80+ 1.78 1.34 - 2.37 3.15 2.52 - 3.93 3.08 2.96 - 3.21
Stage
Localized 1.00 1.00 1.00
Regional 1.48 1.20 - 1.83 1.77 1.49 - 2.10 1.56 1.53 - 1.59
Distant 3.74 2.90 - 4.80 7.96 6.72 - 9.43 6.95 6.78 - 7.12
Morphology
Adenocarcinoma 1.00 1.00 1.00
Others 1.01 0.78 - 1.31 0.63 1.86 - 0.73 0.72 0.71 - 0.74
Surgery
With surgery 1.00 1.00 1.00
Without surgery 2.66 2.21 - 3.21 5.46 4.70 - 6.34 5.19 5.09 - 5.30
Radiotherapy
With radiotherapy 1.00 1.00 1.00
Without radiotherapy 1.03 0.82 - 1.31 1.03 0.86 - 1.22 1.15 1.12 - 1.18
RR, Relative Risk; 95% CI, 95% Confidence Interval
Table 4 Relative risk of death for colorectal cancer patients from the Philippine resident population and for Non-
Hispanic White patients compared to Filipino-American patients from US SEER, 1993-2002
Variable Philippine resident
population
Filipino-Americans (reference
group)
Non-Hispanic
Whites
RR 95% CI RR 95% CI RR 95% CI
Bivariate analysis 1.94 1.76 - 2.13 1.00 — 1.17 1.10 - 1.24
After controlling for other variables (one at a time)
Sex 1.94 1.76 - 2.13 1.00 — 1.17 1.10 - 1.24
Age 2.28 2.07 - 2.51 1.00 — 1.02 0.96 - 1.09
Stage 1.75 1.58 - 1.93 1.00 — 1.24 1.16 - 1.32
Morphology 1.85 1.68 - 2.03 1.00 — 1.18 1.11 - 1.25
Surgery 1.73 1.57 - 1.90 1.00 — 1.21 1.14 - 1.28
Radiotherapy 1.94 1.77 - 2.14 1.00 — 1.16 1.10 - 1.24
Multivariate analysis
1 2.03 1.83 - 2.25 1.00 — 1.12 1.04 - 1.20
RR, Relative Risk; 95% CI, 95% Confidence Interval
1Controlling for all variables in the table
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of malignancy, and with the belief that signs and symp-
toms will eventually cease, CRC patients tend to be
complacent in seeking medical consultation.
Compounding the problem of financial constraints
and lack of awareness is physician delay. A slight major-
ity of CRC patients were initially misdiagnosed by
attending physicians, with Ameobiasis as the most com-
mon initial finding [36]. Due to non-specificity of signs
and symptoms of early disease, CRC symptoms were
sometimes mistaken as that of Ameobiasis or other gas-
trointestinal diseases that are common in the country.
Furthermore, Filipino patients were reported to pre-
sent unique clinicopathological characteristics, including
rare occurrence of polyps [37], and histological findings
suggest the possibility of an alternative tumorgenesis
pathway [37,38]. This implies more difficulty in CRC
detection using endoscopic or radiographic procedures,
and that prevention measures through polyp removal
may not be applicable. Furthermore, the unique pathol-
ogy in Filipinos indicate that current screening guide-
lines in Western countries might not be appropriate
[37]. Various recommendations for CRC screening have
been put forward [39,40], but no program currently
exists in the country. Nevertheless, there are still some
disagreements on what approaches and methods are
most appropriate, particularly in Asian countries [39],
and more research is needed to determine the best
choice of screening strategy.
In our analysis, large survival differences between Phi-
lippine residents and Filipino-American patients per-
sisted even after controlling for stage and other key
prognostic factors in the analysis, suggesting an impor-
tant role of other factors, including peri- and postopera-
tive mortality. The greater proportion of Filipino CRC
cases with advanced stage tumors increases the possibi-
lity of obstruction and high operative mortality. The
additional risks, as well as costs, associated with such
procedures contribute significantly to survival. Access to
cancer care services remain a major challenge, as these
are not affordable for most of the population, even
though government hospitals and clinics offer subsidized
services. Furthermore, the distribution of specialized
centers providing cancer care is disproportionate, with
most being located in major cities.
Between Filipino-Americans and Caucasians, survival
differences are modest, even though very small excess
risk of death for Caucasians remained after adjustment
for multiple covariates including age. Previous studies
have shown that Filipino-Americans have similar CRC
survival as that of non-Hispanic white women [5,6], and
this could be attributed to the high level of health care
access among Filipino-Americans. They are the second
largest Asian-American ethnic group and among the
most acculturated, with majority being either native-born
or naturalized citizens [41]. Among Asian-Americans,
Filipino-Americans were among those who have the
highest income and educational levels, as well as health
insurance and usual source of health care [41]. Although
they have the lowest level of CRC screening as compared
to other ethnic groups, they also have the lowest inci-
dence and mortality rates [42], the latter indicating good
access to treatment. More research though is needed to
ascertain the possible sources of minor survival discre-
pancies between ethnic groups in the US.
Some limitations should be considered in the interpre-
tation of our survival estimates. Our study only covered
variables that were available and comparable in the data-
bases, and not all possible factors that could affect survi-
val were considered. Information not obtainable includes
factors related to cancer services, such as organization,
training and skills of health care professionals, applica-
tion of diagnostic and treatment guidelines, and clinical
factors and histopathologic factors such as tumor differ-
entiation and grade.
Furthermore, in spite of exhausting measures to locate
Philippine patients and to gather survival information,
including personal visits to the homes of those who
could not otherwise be traced, follow-up was not com-
plete. This is primarily because of high population
migration and mobility in the NCR. Patients lost to fol-
low-up were similar to those not lost to follow-up in
terms of age, sex and site-specific distributions. How-
ever, there are more patients diagnosed at later stages
and with stage information unknown among those who
are lost to follow-up (data not shown). It is unlikely that
patients lost to follow-up have higher survival than
those who were not, since it can be assumed that they
have more advanced diseases. Furthermore, it can be
surmised that they have not received any form of treat-
ment, as follow-up data for these patients were not
found in hospitals within the NCR, where majority of
specialized cancer care facilities are located, and the
availability of cancer treatment is limited in the sur-
rounding areas. Given these circumstances, it can be
deduced that the survival estimates are higher than what
could be expected, should follow-up be complete for all
patients.
Conclusions
In conclusion, the differences in CRC survival between
Filipinos and Filipino-Americans underscore the impor-
tance of access to health care. Improving access to and
utilization of diagnostic and treatment facilities and
making them affordable in the Philippines should be
emphasized. Likewise, the important role of health edu-
cation and advocacy, particularly in promoting early
diagnosis and prompt treatment should be given
Redaniel et al. BMC Cancer 2010, 10:100
http://www.biomedcentral.com/1471-2407/10/100
Page 7 of 9priority, for both patients and health practitioners. The
comparison between Filipino-Americans and Caucasians
indicates that CRC survival can be similar in different
ethnic groups, given comparable access to health care.
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